PubMed ID: 34590914 Author(s): Butovich IA, Yuksel S, Leonard B, Gadek T, Polans AS, Albert DM. Novel Lipids of the Rabbit Harderian Gland Improve Tear Stability in an Animal Model of Dry Eye Disease. J …
Arthur Polans
Pilot Study of a “Large-Eye,” Surgically Induced Dry Eye Rabbit Model by Selective Removal of the Harderian, Lacrimal, and Meibomian Glands.
PubMed ID: 29344500 Author(s): Polans AS, McAnulty JF, Phelps PO, Darjatmoko SR, Burris CK, Albert DM. Pilot study of a “large-eye,” surgically induced dry eye rabbit model by selective removal of the harderian, lacrimal, and …
Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
PubMed ID: 27419830 Author(s): Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells …
Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells.
PubMed ID: 26341291 Author(s): van Ginkel PR, Yan MB, Bhattacharya S, Polans AS, Kenealey JD. Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells. Toxicol Appl Pharmacol. 2015 Nov 1;288(3):453-62. doi: …
The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.
PubMed ID: 25361423 Author(s): Kanavi MR, Darjatmoko S, Wang S, Azari AA, Farnoodian M, Kenealey JD, van Ginkel PR, Albert DM, Sheibani N, Polans AS. The sustained delivery of resveratrol or a defined grape powder …
Introducing Krzysztof Palczewski, the 2014 recipient of the Friedenwald award.
PubMed ID: 25338685 Author(s): Polans AS. Introducing Krzysztof Palczewski, the 2014 recipient of the Friedenwald award. Invest Ophthalmol Vis Sci. 2014 Oct 22;55(10):6649-50. doi: 10.1167/iovs.14-14843. PMID 25338685 Journal: Investigative Ophthalmology & Visual Science, Volume 55, …
A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma.
PubMed ID: 23527118 Author(s): Mahida JP, Antczak C, Decarlo D, Champ KG, Francis JH, Marr B, Polans AS, Albert DM, Abramson DH, Djaballah H. A synergetic screening approach with companion effector for combination therapy: application …
Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.
PubMed ID: 21854876 Author(s): Soto BL, Hank JA, Darjatmoko SR, Polans AS, Yanke EM, Rakhmilevich AL, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. Anti-tumor and immunomodulatory activity of resveratrol in vitro and …
Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB.
PubMed ID: 21407133 Author(s): Bhattacharya S, Darjatmoko SR, Polans AS. Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Res. 2011 Jun;21(3):180-7. …